Accelerated diagnostic algorithms with hs-cTn have ≥ 92% sensitivity but lower specificity for diagnosing AMI

Area of Science:

• Cardiology
• Emergency Medicine
• Biomarker Analysis

Background:

• Acute myocardial infarction (AMI) diagnosis can be delayed.
• Early diagnosis is critical for effective treatment and improved patient outcomes.
• High-sensitivity cardiac troponin (hs-cTn) assays offer potential for faster diagnostic timelines.

Purpose of the Study:

• To systematically review and meta-analyze the diagnostic performance of hs-cTn assays.
• To evaluate the impact of hs-cTn on accelerating the diagnosis of AMI.
• To assess the clinical utility of hs-cTn in emergency settings.

Main Methods:

• Systematic literature search for studies evaluating hs-cTn in suspected AMI.
• Meta-analysis of diagnostic accuracy data (sensitivity, specificity).
• Assessment of time-to-diagnosis metrics in included studies.

Main Results:

• Hs-cTn assays demonstrate high diagnostic accuracy for AMI.
• The use of hs-cTn significantly reduces the time required for diagnosis.
• Accelerated diagnosis facilitates earlier therapeutic interventions.

Conclusions:

• High-sensitivity cardiac troponin assays are valuable tools for rapid AMI diagnosis.
• Implementing hs-cTn can streamline emergency department workflows.
• This biomarker testing supports timely management of acute coronary syndromes.